INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q4 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,585 | +35.0% | 538 | +12.8% | 0.00% | +100.0% |
| Q2 2023 | $10,065 | +86.2% | 477 | +50.5% | 0.00% | 0.0% |
| Q1 2023 | $5,405 | -47.8% | 317 | -38.8% | 0.00% | 0.0% |
| Q4 2022 | $10,350 | -35.3% | 518 | -30.5% | 0.00% | -66.7% |
| Q3 2022 | $16,000 | +14.3% | 745 | +8.0% | 0.00% | +50.0% |
| Q2 2022 | $14,000 | -12.5% | 690 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $16,000 | -72.9% | 695 | -68.0% | 0.00% | -77.8% |
| Q4 2021 | $59,000 | – | 2,174 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |